Clinical Trials Directory

Trials / Conditions / Recurrent Gliosarcoma

Recurrent Gliosarcoma

15 registered clinical trials studyying Recurrent Gliosarcoma — 6 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingTesting the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patie
NCT07422363
National Cancer Institute (NCI)Phase 1
RecruitingGI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Gliob
NCT07301268
Mayo ClinicPhase 2
RecruitingPhase I CB-NK-TGF-ßR2-/NR3C1- in rGBM
NCT04991870
M.D. Anderson Cancer CenterPhase 1
RecruitingEfineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma
NCT05465954
Mayo ClinicPhase 2
RecruitingAtezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma
NCT05039281
M.D. Anderson Cancer CenterPhase 1 / Phase 2
WithdrawnInducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or Gliosarcoma
NCT05017610
Emory UniversityEARLY_Phase 1
WithdrawnONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent Glioblastoma
NCT04854044
Jonsson Comprehensive Cancer CenterPhase 1
Active Not RecruitingMycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma
NCT04477200
University of Michigan Rogel Cancer CenterPhase 1
RecruitingMSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
NCT03896568
M.D. Anderson Cancer CenterPhase 1
TerminatedIntracerebral EGFR-vIII CAR-T Cells for Recurrent GBM
NCT03283631
Gary Archer Ph.D.Phase 1
Active Not RecruitingCarboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients Wit
NCT02192359
City of Hope Medical CenterPhase 1
Active Not RecruitingPembrolizumab in Treating Patients With Recurrent Glioblastoma
NCT02337686
M.D. Anderson Cancer CenterPhase 2
CompletedVaccine Therapy in Treating Patients With Recurrent Glioblastoma
NCT03360708
Mayo ClinicEARLY_Phase 1
CompletedBi-weekly Temozolomide Plus Bevacizumab for Adult Patients With Recurrent Glioblastoma Multiforme
NCT00883298
Center for Neurosciences, TucsonPhase 2
Active Not RecruitingLonafarnib and Temozolomide in Treating Patients with Glioblastoma Multiforme That is Recurrent or Did Not Res
NCT00102648
M.D. Anderson Cancer CenterPhase 1